Total words: 3270 | 2-word phrases: 847 | 3-word phrases: 974 | 4-word phrases: 1023
Title | Try to keep the title under 60 characters (55 characters) GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% |
Description | Try to keep the meta description between 50 - 160 characters (143 characters) Learn about GAMMAGARD LIQUID. See Information for Patients, including Warning about Blood Clots, Decreased Kidney Function, and Kidney Failure. |
Keywords | Meta keywords are not recommended anymore (0 characters) |
H1 | H1 tag on the page (72 characters) The most prescribed IG in the US for 15 years1 (Based on combined data*) |
# | Keyword | H1 | Title | Des | Volume | Position | Suggest | Frequency | Density |
---|---|---|---|---|---|---|---|---|---|
1 | or | 72 | 16.90% | ||||||
2 | the | 53 | 12.44% | ||||||
3 | of | 47 | 11.03% | ||||||
4 | a | 46 | 10.80% | ||||||
5 | gammagard | 43 | 10.09% | ||||||
6 | in | 42 | 9.86% | ||||||
7 | liquid | 35 | 8.22% | ||||||
8 | to | 33 | 7.75% | ||||||
9 | and | 28 | 6.57% | ||||||
10 | for | 28 | 6.57% |
# | URL | Whois | Check |
---|---|---|---|
1 | https://www.shirecontent.com/PI/PDFs/Gamliquid_USA_ENG.pdf | Whois | shirecontent.com |
2 | https://www.shirecontent.com/PI/PDFs/Gamliquid_USA_ENG.pdf | Whois | shirecontent.com |
3 | https://www.shirecontent.com/pi/pdfs/gamliquid_usa_eng.pdf#page=31 | Whois | shirecontent.com |
4 | https://www.fda.gov/medwatch | Whois | fda.gov |
5 | https://www.shirecontent.com/pi/pdfs/gamliquid_usa_eng.pdf#page=31 | Whois | shirecontent.com |
6 | https://www.fda.gov/medwatch | Whois | fda.gov |
7 | https://www.takeda.com/en-us/terms-of-use/ | Whois | takeda.com |
8 | https://www.takeda.com/en-us/who-we-are/contact-us/ | Whois | takeda.com |
9 | https://www.shirecontent.com/PI/PDFs/Gamliquid_USA_ENG.pdf | Whois | shirecontent.com |
10 | https://www.takeda.com/privacy-notice/ | Whois | takeda.com |
11 | https://www.takeda.com/en-us/who-we-are/ | Whois | takeda.com |
12 | https://www.takeda.com/en-us | Whois | takeda.com |